SHILPA MEDICARE
|
SHILPA MEDICARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -3.74 | 6.99 | 18.13 | 19.15 | 13.77 |
| CEPS(Rs) | 7.44 | 16.17 | 24.55 | 24.33 | 18.59 |
| DPS(Rs) | - | 1.10 | 1.10 | 1.10 | 1.00 |
| Book NAV/Share(Rs) | 205.44 | 209.93 | 181.37 | 163.06 | 146.89 |
| Tax Rate(%) | 19.24 | 40.76 | 25.04 | 17.81 | 19.29 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 8.41 | 17.21 | 19.05 | 23.63 | 21.00 |
| EBIT Margin(%) | 1.94 | 12.52 | 24.07 | 21.21 | 19.00 |
| Pre Tax Margin(%) | -3.65 | 8.93 | 21.65 | 20.71 | 18.50 |
| PAT Margin (%) | -2.94 | 5.29 | 16.22 | 17.02 | 14.93 |
| Cash Profit Margin (%) | 6.15 | 12.26 | 22.21 | 21.85 | 20.67 |
| Performance Ratios | |||||
| ROA(%) | -1.07 | 2.20 | 6.33 | 8.59 | 7.04 |
| ROE(%) | -1.71 | 3.67 | 10.41 | 12.23 | 9.59 |
| ROCE(%) | 0.80 | 5.94 | 10.73 | 12.38 | 10.45 |
| Asset Turnover(x) | 0.36 | 0.42 | 0.39 | 0.50 | 0.47 |
| Sales/Fixed Asset(x) | 0.59 | 0.73 | 0.75 | 0.99 | 0.89 |
| Working Capital/Sales(x) | -70.47 | 4.16 | 3.28 | 4.26 | 2.51 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.70 | 1.37 | 1.34 | 1.01 | 1.12 |
| Receivable days | 123.51 | 98.75 | 97.28 | 90.56 | 105.51 |
| Inventory Days | 117.32 | 109.68 | 113.34 | 83.24 | 93.66 |
| Payable days | 127.45 | 106.00 | 113.98 | 113.86 | 130.97 |
| Valuation Parameters | |||||
| PER(x) | - | 56.83 | 18.42 | 12.77 | 24.71 |
| PCE(x) | 30.83 | 24.56 | 13.59 | 10.05 | 18.30 |
| Price/Book(x) | 1.12 | 1.89 | 1.84 | 1.50 | 2.32 |
| Yield(%) | - | 0.28 | 0.33 | 0.45 | 0.29 |
| EV/Net Sales(x) | 2.63 | 3.57 | 3.82 | 2.58 | 3.92 |
| EV/Core EBITDA(x) | 23.11 | 18.78 | 16.25 | 9.88 | 16.94 |
| EV/EBIT(x) | 135.78 | 28.55 | 15.87 | 12.14 | 20.62 |
| EV/CE(x) | 0.95 | 1.42 | 1.31 | 1.18 | 1.78 |
| M Cap / Sales | 1.90 | 3.01 | 3.02 | 2.20 | 3.78 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -8.33 | 27.12 | -0.75 | 23.80 | -7.03 |
| Core EBITDA Growth(%) | -45.13 | 2.98 | -10.54 | 39.62 | -7.77 |
| EBIT Growth(%) | -85.80 | -33.88 | 12.62 | 38.22 | -0.05 |
| PAT Growth(%) | -151.03 | -58.56 | -5.41 | 41.15 | 6.45 |
| EPS Growth(%) | -153.54 | -61.45 | -5.36 | 39.10 | 6.67 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.45 | 0.37 | 0.57 | 0.29 | 0.16 |
| Current Ratio(x) | 0.98 | 1.45 | 1.47 | 1.52 | 2.15 |
| Quick Ratio(x) | 0.57 | 0.88 | 0.90 | 0.97 | 1.41 |
| Interest Cover(x) | 0.35 | 3.48 | 9.92 | 42.26 | 37.91 |
| Total Debt/Mcap(x) | 0.40 | 0.20 | 0.31 | 0.20 | 0.07 |
Compare Financial Ratios of peers of SHILPA MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHILPA MEDICARE | ₹5,194.6 Cr | 0.8% | 1.1% | 84% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹356,625.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
| CIPLA | ₹112,938.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹101,315.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,276.9 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹93,921.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
SHILPA MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHILPA MEDICARE | 0.8% |
1.1% |
84% |
| SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses
